Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Drug discovery services industry 3600synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Process trends
2.1.4 Type trends
2.1.5 Drug type trends
2.1.6 Therapeutic area trends
2.1.7 End-user trends
Chapter 3 Drug Discovery Services Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing R&D expenditure
3.2.1.2 Rising prevalence of chronic disease
3.2.1.3 Rising demand for novel therapeutic drugs for treatment
3.2.1.4 Rising technological advancements in drug discovery
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulations governing drug discovery
3.3 Growth potential analysis
3.3.1 By process
3.3.2 By type
3.3.3 By drug type
3.3.4 By therapeutic area
3.3.5 By end-user
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6 Technological landscape
3.7 Drug discovery and development process
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
4.6 Strategy outlook matrix
Chapter 5 Drug Discovery Services Market Size and Forecast, By Process (USD Million)
5.1 Key trends, by process
5.2 Target Selection
5.3 Target Validation
5.4 Hit-to-Lead Identification
5.5 Lead Optimization
5.6 Candidate Validation
Chapter 6 Drug Discovery Services Market Size and Forecast, By Type (USD Million)
6.1 Key trends, by type
6.2 Chemistry Services
6.3 Biological Services
Chapter 7 Drug Discovery Services Market Size and Forecast, By Drug Type (USD Million)
7.1 Key trends, by drug type
7.2 Small-molecule Drugs
7.3 Large-molecule Drugs
Chapter 8 Drug Discovery Services Market Size and Forecast, By Therapeutic Area (USD Million)
8.1 Key trends, by therapeutic area
8.2 Diabetes
8.3 Neurology
8.4 Oncology
8.5 Infectious Diseases
8.6 Other therapeutic areas
Chapter 9 Drug Discovery Services Market Size and Forecast, By End-user (USD Million)
9.1 Key trends, by end-user
9.2 Pharmaceutical & Biotechnology Companies
9.3 Contract Research Organizations
9.4 Other End-users
Chapter 10 Drug Discovery Services Market Size and Forecast, By Region (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 MEA
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of MEA
Chapter 11 Company Profiles
11.1 Charles River Laboratories International, Inc.
11.2 QIAGEN
11.3 Thermo Fisher Scientific, Inc.
11.4 Wuxi AppTec
11.5 Merck & Co. Inc.
11.6 Eurofins Scientific
11.7 GenScript
11.8 Laboratory Corporation of American Holdings
11.9 EVOTEC
11.10 Curia Global, Inc.
11.11 Syngene International Limited
11.12 TCG Lifesciences Pvt Ltd.
11.13 TheraIndx Lifesciences Pvt. Ltd.
